Evidence map›Paper›PMID 32365988›Full record

ReviewInternational journal of molecular sciences2020

The Expression and Function of CD300 Molecules in the Main Players of Allergic Responses: Mast Cells, Basophils and Eosinophils.

Joana Vitallé, Iñigo Terrén, Ane Orrantia, Agurtzane Bilbao, Pedro M Gamboa, Francisco Borrego, Olatz Zenarruzabeitia

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Dynamic regulation of CD300b and CD300f on myeloid cells in oral immunotherapy.The journal of allergy and clinical immunology. Global · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Potential Role of Moesin in Regulating Mast Cell Secretion.International journal of molecular sciences · 2023
    Review
  8. Article
  9. Review
  10. Article
  11. TET2 Regulates 5-Hydroxymethylcytosine Signature and CD4Allergy, asthma & immunology research · 2022
    Article
  12. Article
  13. Article
  14. Strategies for Mast Cell Inhibition in Food Allergy.The Yale journal of biology and medicine · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Joana VitalléImmunopathology Group, Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain.
Iñigo TerrénImmunopathology Group, Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain.ORCID 0000-0002-8099-3916
Ane OrrantiaImmunopathology Group, Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain.
Agurtzane BilbaoImmunopathology Group, Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain.
Pedro M GamboaImmunopathology Group, Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain.
Francisco BorregoImmunopathology Group, Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain.ORCID 0000-0002-3105-981X
Olatz ZenarruzabeitiaImmunopathology Group, Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain.ORCID 0000-0002-0869-9034
BioCruces Health research Institute · ESIkerbasque · ES

Funding

Eusko Jaurlaritza PRE_2017_2_0242Eusko Jaurlaritza PRE_2018_1_0032Instituto de Salud Carlos III CD17/00128Instituto de Salud Carlos III PI16/01223Jesús de Gangoiti Barrera Foundation FJGB18/002Jesús de Gangoiti Barrera Foundation FJGB19/002Osasun Saila, Eusko Jaurlaritzako 2019111031
6 · The paper itself

Abstract

Allergy is the host immune response against non-infectious substances called allergens. The prevalence of allergic diseases is increasing worldwide. However, while some drugs counteract the symptomatology caused by allergic reactions, no completely effective treatments for allergic diseases have been developed yet. In this sense, the ability of surface activating and inhibitory receptors to modulate the function of the main effector cells of allergic responses makes these molecules potential pharmacological targets. The CD300 receptor family consists of members with activating and inhibitory capabilities mainly expressed on the surface of immune cells. Multiple studies in the last few years have highlighted the importance of CD300 molecules in several pathological conditions. This review summarizes the literature on CD300 receptor expression, regulation and function in mast cells, basophils and eosinophils, the main players of allergic responses. Moreover, we review the involvement of CD300 receptors in the pathogenesis of certain allergic diseases, as well as their prospective use as therapeutic targets for the treatment of IgE-dependent allergic responses.

Indexed as

AnimalsBasophilsEosinophilsHumansHypersensitivityImmunoglobulin EMast CellsImmunoglobulin Eallergyatopic dermatitisbasophilsCD300 receptorsceramideeosinophilsFcɛRIIgEmast cellsphosphatidylethanolaminephosphatidylserine

Identifiers

PMID32365988
PMCPMC7247439
OpenAlexW3023059147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.